Stock ANRO ALTO NEUROSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Alto Neuroscience, Inc.

Equities

ANRO

US02157Q1094

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-07 pm EDT 		5-day change 1st Jan Change
11.81 USD +0.34% Intraday chart for Alto Neuroscience, Inc. -1.25% 0.00%
May. 21 Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer CI
May. 14 Alto Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Alto Neuroscience, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5b0.4jpimX-0TvAeFSuhK1ZQa3X16cBajrrLW5j6s7KBuoE.hHcQySXaL8dRRXHPfDwnAA-Yo48sw9e6bKmM_fX47vbTSVPWO-URvytfeg~72a6f21a9eec6f850e74e318f9e9bdb5

Analyst Recommendations on Alto Neuroscience, Inc.

Stifel Initiates Alto Neuroscience With Buy Rating, Price Target is $32 MT
Baird Initiates Alto Neuroscience With Outperform Rating, Price Target is $32 MT
Jefferies Initiates Alto Neuroscience With Buy Rating, Price Target is $33 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
11.81 USD
Average target price
33.69 USD
Spread / Average Target
+185.27%
High Price Target
37.76 USD
Spread / Highest target
+219.73%
Low Price Target
32 USD
Spread / Lowest Target
+170.96%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alto Neuroscience, Inc.

Baird
Jefferies & Co.
Stifel Nicolaus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ANRO Stock
  4. Consensus Alto Neuroscience, Inc.